Additionally, we analyzed the clinicopathological data of 44 non-small cell lung cancer patients receiving ICI (anti-PD-1 antibody) and identified the Eastern Cooperative Oncology Group performance status (ECOG PS), pathological type, standardized uptake value (SUV) on PET, white blood cell count, neutrophil, neutrophil-to-lymphocyte ratio (NLR), lactate dehydrogenase and albumin as independent prognostic factors in multivariate analyses [62]. The gene discussed is ALB; the disease is non-small cell lung carcinoma.